Tag

dermatology education

Evaluating Skin Findings of Systemic Disease

By ODAC Sessions

skin findings of systemic disease

At the 2026 ODAC Dermatology Conference, attendees had the opportunity to learn about evaluating skin findings of systemic disease from Olayemi Sokumbi, MD, FAAD, professor of dermatology and laboratory medicine & pathology at Mayo Clinic. Dr. Sokumbi shared her expertise about evaluating skin findings that may occur in the context of systemic illness, emphasizing a structured derm-dermpath approach. Through two illustrative cases, she demonstrated how the skin serves as an early window to systemic disease and how clinicopathologic correlation (CPC) is integral to establishing the correct diagnosis.

Case 1:

Dr. Sokumbi described a gentleman in his 50s who presented with skin-colored papules on the ears accompanied by joint pains. The presence of concurrent systemic symptoms raised suspicion for an underlying systemic process, prompting a skin biopsy. Histopathology revealed foamy xanthomatous histiocytes, suggesting a non-Langerhans cell histiocytosis with inflammatory arthritis such as Erdheim-Chester disease (EDC). However, at least half of cases of EDC cases demonstrate a BRAF V600E mutation.1 Staining of this skin biopsy was negative for this mutation, prompting Dr. Sokumbi to return to the bedside and broaden the differential diagnosis. Subsequent physical examination revealed periungual papules and nodules, in a characteristic “coral beading” pattern, leading to the diagnosis of multicentric reticulohistiocytosis (MRH), a condition also associated with severe polyarthritis. The histopathologic pitfall requiring CPC was the presence of xanthomatized histiocytes, which are typical for EDC and underrecognized in MRH due to the rarity of this finding. Accurate diagnosis carries significant clinical implications, as MRH has a strong association with solid organ malignancy and requires therapeutic approaches distinct from those used in EDC.

Case 2:

Dr. Sokumbi presented the case of a young lady with diffuse cutaneous hyperpigmentation, which multiple providers had attributed to dermatoheliosis or photoaging. She highlighted, however, key photoprotected areas, such as the conchal bowls of the ears, also demonstrated blue-gray discoloration. The clinical differential diagnoses included lichen planus pigmentosus and argyria, yet the characteristic histopathologic features of these entities were not present on skin biopsy.

Instead, histologic examination revealed wavy deposits within the dermis that stained basophilic on Hematoxylin and Eosin and blue-black with Verhoeff Van Gieson (VVG) staining. Basophilic collagen fibers and altered deposits of elastic fibers have been reported as early-stage findings of ochronosis,3 in contrast to the classic late-stage yellow-brown banana-shaped collagen fibers. Based on these findings the patient was diagnosed with endogenous ochronosis/alkaptounuria, a genodermatosis characterized by impaired breakdown of tyrosine and phenylalanine.

In conclusion, Dr. Sokumbi emphasized how dermatologists are often uniquely positioned to diagnose systemic disease through careful evaluation of skin findings. Both cases underscored the importance of CPC. She encouraged repeating skin biopsies when the leading diagnosis remains unclear and collaborating with colleagues across specialties to ensure comprehensive management of systemic disease.

This session summary was written by Nagasai Adusumilli, MD, MBA, chief resident physician in dermatology at the George Washington University School of Medicine and Health Sciences.

References

  1. Haroche J, Cohen-Aubart F, Emile JF, et al. Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease. J Clin Oncol. 2015 Feb 10;33(5):411-8. PMID: 25422482.
  2. Camargo K, Pinkston O, Abril A, Sluzevich JC. Xanthomatous multicentric reticulohistiocytosis: an underrecognized variant. J Clin Rheumatol. 2018 Aug;24(5):285-287. PMID: 29239933.
  3. Chowdary S, Mahalingam M, Vashi NA. Reading between the layers: early histopathological findings in exogenous ochronosis. Am J Dermatopathol. 2014 Dec;36(12):989-91.PMID: 25415140.

ODAC Expands Advisory Team

By ODAC Sessions

ODAC Advisory Team

The ODAC Advisory Team is growing!

Jennifer Soung, MD, FAAD, will serve as a medical dermatology advisor. Dr. Soung is a dermatologist in private practice in Santa Ana, Calif., and an associate professor at Harbor-UCLA Medical Center.

“Education has always been at the heart of my work in dermatology, and I have long believed that high-quality education is the foundation of exceptional patient care,” Dr. Soung says. “As ODAC’s medical dermatology advisor, I’m excited to collaborate with the advisory team to further strengthen medical dermatology education—bringing evidence-based insights, clinical relevance, and my enthusiasm, expertise, and genuine joy for dermatology to colleagues across the field.”

Vishal A. Patel, MD, FACMS, will serve as a conference co-chair. Dr. Patel, a longtime faculty member, was previously ODAC’s guest advisor for surgical dermatology. He is an associate professor of dermatology and director of the Cutaneous Oncology Program at GWU School of Medicine & Health Sciences.

“I’m honored to step into the role of ODAC conference co-chair and help shape the next chapter of this remarkable meeting,” Dr. Patel says. “Serving as a special advisor has been a privilege, and I’m proud of the work we’ve already done to elevate the conference’s impact. I’m excited to build on that momentum by expanding our surgical dermatology and cutaneous oncology offerings with innovative, practical education that empowers clinicians to elevate patient care.”

ODAC Conference Co-Chair Adam Friedman, MD, FAAD, says these changes to the ODAC Advisory Team make for an exciting time for ODAC. “In Dr. Patel’s expanded role as co-chair, and Dr. Soung as medical advisor, they will no doubt further strengthen ODAC’s mission to deliver innovative AND practical education that truly meets the needs of today’s dermatology community.”

“ODAC continues to evolve with the times as dermatology changes,” says ODAC Conference Co-Chair Susan H. Weinkle, MD, FAAD. “We are proud to have Drs. Patel and Soung in their new roles on the advisory team as we continue to enhance our surgical and medical dermatology offerings. This is a forward-thinking change that will lead to improved patient care.”

Save the Date! ODAC 2027 will take place Friday, January 15, through Monday, January 18, 2027, in Orlando at the Signia by Hilton Orlando Bonnet Creek.

What’s New in Rosacea: Interview with Dr. Adam Friedman

By ODAC Sessions

rosacea

ODAC Co-Chair Adam Friedman, MD, FAAD, says he’s changed the way he approaches rosacea due to some nuances in recently published studies.

Watch this Next Steps in Derm video interview with Dr. Friedman from ODAC 2025 where he addresses what’s new in the understanding of rosacea triggers. Does current research support the longstanding guidance to avoid coffee? Plus learn Dr. Friedman’s top strategies for managing rosacea and find out about three recently FDA-approved rosacea therapies.

Don’t miss Dr. Friedman’s rosacea session at ODAC 2026 where he’ll address more new developments and practical approaches. Register today!

Inpatient Consultations at ODAC with Dr. Olayemi Sokumbi

By ODAC Sessions

best practices in examining a dermatology inpatient

ODAC covers a breadth of topics in dermatology, including how to approach inpatient dermatological consultations. Next Steps in Derm, in partnership with ODAC, interviewed Olayemi Sokumbi, MD, about her ODAC 2025 session on best practices in examining an inpatient.

Watch as Dr. Sokumbi shares three categories you need to consider in your initial exam of an inpatient. Plus hear why a close partnership with a dermatopathologist is important in making an accurate diagnosis.

Register for ODAC 2026 for more pearls and updates in dermatology.

Procedures in Kids at ODAC: Tips with A. Yasmine Kirkorian, MD

By ODAC Sessions

dermatology procedures in children

Pediatric dermatology pearls are part of the ODAC educational focus. Next Steps in Derm, in partnership with ODAC, interviewed A. Yasmine Kirkorian, MD, about her ODAC 2025 session on hot tips for procedures in kids.

Watch as Dr. Kirkorian shares why you might want to reconsider some procedures. If you move forward with a procedure, learn how to appropriately involve the parent and other medical staff. Plus find out when you might want to consider moving a procedure to the OR.

Register for ODAC 2026 for more pediatric dermatology updates.